91 studies found for:    Open Studies | "Sexual Dysfunctions, Psychological"
Show Display Options
Rank Status Study
21 Not yet recruiting Research and Clinical Value of New Classification for Premature Ejaculation
Condition: Premature Ejaculation
Intervention:
22 Recruiting A Phase 2 Study of On-demand Therapy With Clomipramine and Sildenafil Combination in Premature Ejaculation
Condition: Premature Ejaculation
Interventions: Drug: CDFR0812-15/25mg;   Drug: CDFR0812-15/50mg;   Drug: Condencia;   Drug: CDFR0812-Placebo;   Drug: Condencia-Placebo
23 Recruiting Preservation of Endopelvic Fascia: Effects on Postoperative Incontinence and Impotence. Randomized Clinical Trial.
Conditions: Prostatic Neoplasms;   Urinary Incontinence;   Erectile Dysfunction
Interventions: Procedure: Preservation (endopelvic fascia);   Procedure: Opening (endopelvic fascia)
24 Recruiting DHACM in Robotic Assisted Laparoscopic Prostatectomy (RALP)
Condition: Erectile Dysfunction
Interventions: Procedure: RALP using full nerve sparing technique;   Other: dHACM Application
25 Recruiting GEnder Dysphoria Treatment in Sweden
Condition: Transsexualism
Interventions: Other: Genetic men treated with estrogen;   Other: Genetic women treated with androgen
26 Recruiting Efficacy and Tolerability Study of Avanafil in Russia
Condition: Sexual Function and Fertility Disorders NEC-Erectile Dysfunction
Interventions: Drug: AVANAFIL;   Drug: placebo
27 Not yet recruiting Safety and Clinical Efficacy of Local Topical Treatment for Erectile Dysfunction
Condition: Erectile Dysfunction
Intervention: Drug: VL#FIA3-30
28 Recruiting Clinical Trial of Topically-applied Glyceryl Trinitrate (GTN) for the Treatment of Erectile Dysfunction (ED)
Condition: Erectile Dysfunction
Interventions: Drug: Glyceryl trinitrate;   Drug: MED Placebo
29 Not yet recruiting Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Arteriogenic Erectile Dysfunction
Condition: Impotence, Arteriogenic
Intervention: Device: Bioabsorbable everolimus-eluting stent deployment
30 Not yet recruiting Dyspareunia in Women With Endometriosis: Impact of Surgery on Sexual Health
Conditions: Dyspareunia;   Endometriosis
Intervention: Behavioral: Questionnaires
31 Not yet recruiting Intraoperative Nerve Monitoring During Robot-assisted Laparoscopic Prostatectomy
Conditions: Urinary Incontinence;   Erectile Dysfunction
Intervention: Device: Intraoperative nerve monitoring
32 Recruiting Transperineal Ultrasound to Assess the Progress of Labour
Conditions: Placenta Praevia;   Vaginismus
Intervention:
33 Recruiting Management of Peyronie's Disease With Adipose Tissue Stem Cell
Conditions: Erectile Dysfunction;   Peyronie' Disease
Intervention: Drug: Adipose tissue stem cell injection
34 Recruiting A Phase 2a, Single-Dose, Double-Blind, Placebo-Controlled, 2-Way Crossover Study Using Penile Plethysmography to Evaluate the Efficacy and Safety of SST-6006, a Topical Sildenafil Cream (5% w/w), Compared to Placebo in the Treatment of Erectile Dysfunction
Condition: Erectile Dysfunction
Interventions: Drug: Sildenafil;   Drug: Placebo
35 Not yet recruiting Consultations Reason for Genital, Urinary or Psychological Humans in General Practice
Condition: Premature Ejaculation
Interventions: Other: Questionary SF12 and PEDT;   Other: Total attention;   Other: Humour;   Other: Take the drama out;   Other: Question about premature ejaculation;   Other: Symptoms of premature ejaculation;   Other: Help to verbalize
36 Recruiting Safety of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Erectile Dysfunction
Condition: Erectile Dysfunction
Intervention: Drug: mesenchymal stem cell (Cellgram-ED)
37 Recruiting Effect of Vardenafil on Erectile Dysfunction and Portal Hemodynamics in Patients With Liver Cirrhosis
Conditions: Cirrhosis;   Erectile Dysfunction
Interventions: Drug: Vardenafil;   Procedure: HVPG (Hepatic venous pressure measurement) baseline;   Procedure: HVPG (Hepatic venous pressure measurement) day 7;   Behavioral: IIEF 5 (International Index of Erectile Function) questionaire baseline;   Behavioral: IIEF 5 (International Index of Erectile Function) questionnaire at study phase end;   Drug: Placebo intake once daily
38 Recruiting Low Energy Shockwave Therapy for Improving Erectile Dysfunction
Condition: Erectile Dysfunction
Interventions: Other: Pre-inclusion questionnaires;   Drug: 1 month of PDE5i treatment;   Other: PDE5i follow-up questionnaires;   Other: Inclusion questionnaires;   Device: 4 weekly LIESWT (Wave 1) with the RENOVA device;   Device: 4 weekly sham LIESWT (Wave 1) with the RENOVA device;   Other: Follow-up questionnaires 1 month after Wave 1;   Other: Follow-up questionnaires 3 months after Wave 1;   Device: 8 bi-weekly LIESWT (Wave 2) with the RENOVA device;   Other: Follow-up questionnaires 1 month after Wave 2;   Other: Questionnaires via postal mail;   Other: Final follow-up questionnaires 12 months after Wave 2
39 Recruiting Continuous Versus Cyclic Oral Contraceptives for Endometriosis
Conditions: Dysmenorrhea;   Pelvic Pain;   Dyspareunia;   Endometrioma
Interventions: Drug: Oral contraceptives cyclic;   Drug: Oral contraceptives continuous
40 Recruiting Sagene 2014 - Parkinson's Disease and Erectile Dysfunction
Conditions: Parkinson's Disease;   Erectile Dysfunction
Interventions: Drug: Selegiline;   Drug: Tadalafil

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years